Strong Revenue Growth Drives Increase of 12.3% in EPS and 18.5% in Operating Cash Flow BURLINGTON, N.C.(BUSINESS WIRE) Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH) today announced results [...]
WEST CHESTER, Ohio(BUSINESS WIRE) AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced that it received clearance from the FDA for its AtriClip Gillinov-Cosgrove Left Atrial [...]
WEST CHESTER, Ohio – (BUSINESS WIRE) – AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced that it received clearance from the FDA for its AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion system. The AtriClip system is designed to safely and effectively exclude the left atrial appendage. [...]
VIENNA, Va.(BUSINESS WIRE) CEL-SCI Corporation (NYSE AMEX: CVM) today provided an update on its planned Phase III clinical trial of its cancer immunotherapy drug candidate Multikine. The Company, together with its development partners Teva Pharmaceutical [...]
Deal continues in-network coverage for Aetna members at the hospital and with physicians who admit patients to Stony Brook HARTFORD, Conn.(BUSINESS WIRE) Aetna (NYSE: AET) and Stony Brook [...]
VALENCIA, Calif.(BUSINESS WIRE) MannKind Corporation (Nasdaq:MNKD) today announced that it has received a Complete Response letter from the U.S. Food & Drug Administration (FDA) regarding the New Drug Application (NDA) for AFREZZA? (insulin human [rDNA [...]
Previously Announced Corporate Name Change to Bohai Pharmaceuticals Group, Inc. Results in New Ticker (OTCBB:BOPH) YANTAI, China(BUSINESS WIRE) Bohai Pharmaceuticals Group, Inc. (Bohai?) (OTCBB:BOPH) today announced that the company’s [...]
BOULDER, Colo.(BUSINESS WIRE) Array BioPharma Inc. (Nasdaq: ARRY) today reported financial results for the second quarter of fiscal 2010. Array reported revenue of $9.6 million for the second quarter of fiscal [...]
SAN DIEGO, Jan. 28, 2010 (GLOBE NEWSWIRE) Vical Incorporated (Nasdaq:VICL) today announced that the company has completed enrollment of the planned 375 subjects in its multinational Phase 3 trial of Allovectin-7 in patients with metastatic melanoma. Allovectin-7 is a novel gene-based immunotherapeutic with a unique mechanism of action that is fundamentally different from currently [...]
WICHITA, Kan.(BUSINESS WIRE) Pulse Systems, Inc., an industry leading healthcare software and services organization, today announced the company’s electronic health records (EHR) product, included in Pulse Patient Relationship Management 4.1.02, [...]
